Suraksha Diagnostic IPO
IPO Listing Details
- Listing Date
06 Dec 2024
- Listing Price
₹437.00
- Listing Change
-0.91%
- Last Traded Price
₹406.75
IPO Details
- Open Date
29 Nov 2024
- Close Date
03 Dec 2024
- IPO
Price Range
₹ 420 to ₹ 441
- IPO
Size
₹ 846.25 Cr
- Listing Exchange
BSE NSE
- Listing Date
06 Dec 2024
IPO Timeline
Suraksha Diagnostic IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 29-Nov-24 | 0.04 | 0.02 | 0.20 | 0.11 |
| 2-Dec-24 | 0.00 | 0.13 | 0.45 | 0.25 |
| 3-Dec-24 | 1.74 | 1.40 | 0.94 | 1.27 |
Last Updated: 03 December 2024 6:56 PM by 5Paisa
Suraksha Diagnostic IPO is set to open on 29 November 2024 and will close on 3 December 2024. Suraksha Diagnostic is a prominent provider of pathology, radiology, and medical consultancy services.
The IPO is entirely an offer for sale of 1.92 Cr shares aggregating ₹846.25 Cr. The price range is set between ₹420 to ₹441 per share and the lot size is 34 shares.
The allotment is scheduled to be finalised on 4 December 2024. It will go public on NSE SME, with a tentative listing date of 6 December 2024.
ICICI Securities Ltd, Nuvama Wealth Management Ltd and SBI Capital Markets Ltd are the book running lead managers while Kfin Technologies Ltd is the registrar.
Suraksha IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹846.25 Cr |
| Offer For Sale | ₹846.25 Cr |
| Fresh Issue | - |
Suraksha IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 34 | ₹14,994 |
| Retail (Max) | 13 | 442 | ₹194,922 |
| S-HNI (Min) | 14 | 476 | ₹209,916 |
| S-HNI (Max) | 66 | 2,244 | ₹989,604 |
| B-HNI (Min) | 67 | 2,278 | ₹1,004,598 |
Suraksha IPO Reservation
| Investors Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Cr.) |
|---|---|---|---|---|
| QIB | 1.74 | 38,37,867 | 66,67,332 | 294.029 |
| NII (HNI) | 1.40 | 28,78,400 | 40,42,124 | 178.258 |
| Retail | 0.94 | 67,16,266 | 62,99,078 | 277.789 |
| Total | 1.27 | 1,34,32,533 | 1,70,08,534 | 750.076 |
Suraksha IPO Anchor Allocation
| Anchor Bid Date | 28 November, 2024 |
| Shares Offered | 5,756,797 |
| Anchor portion Size (In ₹ Cr.) | 253.87 |
| Anchor lock-in period end date for 50% shares (30 Days) | 03 January, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | 04 March, 2025 |
The IPO proceeds will not be utilized for the company’s operations or growth plans. Instead, the purpose of the IPO is to enable existing shareholders to divest their holdings and exit the business.
Suraksha Diagnostic, is a prominent provider of pathology, radiology, and medical consultancy services. With a robust infrastructure comprising a central reference laboratory, eight satellite labs, and 215 customer touchpoints—including 49 diagnostic centers and 166 sample collection facilities—the company operates across West Bengal, Bihar, Assam, and Meghalaya. Its 44 diagnostic centers also house 120 polyclinics with over 750 doctors, offering both online and offline medical consultations. Leveraging advanced systems like Laboratory Information Management System (LIMS), Radiology Information System (RIS), Picture Archive Communication System (PACS), and Enterprise Resource Planning (ERP), Suraksha ensures streamlined operations and reduced turnaround times.
The company specializes in vaccination services and customized testing packages for early disease detection, utilizing digital pathology and AI-driven blood test generation. Suraksha’s competitive edge lies in its integrated service model, advanced clinical infrastructure, and a strong focus on quality, ensuring high customer retention in fragmented eastern and northeastern Indian markets.
Peers
Dr. Lal PathLabs
Metropolis Healthcare
Thyrocare
Vijaya Diagnostic
| Particulars (in Rs. Crores) | FY24 | FY23 | FY22 |
|---|---|---|---|
| Revenue | 222.26 | 193.69 | 225.77 |
| EBITDA | 73.62 | 47.48 | 65.25 |
| PAT | 23.13 | 6.07 | 20.82 |
| Particulars (in Rs. Crores) | FY24 | FY23 | FY22 |
|---|---|---|---|
| Total Assets | 300.21 | 281.20 | 275.96 |
| Share Capital | 6.90 | 6.90 | 6.90 |
| Total Borrowings | 8.64 | 14.01 | 19.03 |
| Particulars (in Rs. Crores) | FY24 | FY23 | FY22 |
|---|---|---|---|
| Net Cash Generated From / (used in) operating activities | 60.48 | 44.10 | 57.82 |
| Net Cash Generated From / (used in) Investing Activities | -35.00 | -20.80 | -43.28 |
| Net Cash Generated From / (used in) financing activities | -25.13 | -24.33 | -14.28 |
| Net Increase (Decrease) In Cash And Cash Equivalents | 0.36 | -1.03 | 0.26 |
Strengths
1. Extensive network across eastern and northeastern India.
2. Integrated pathology, radiology, and consultancy services under one roof.
3. Advanced technology platforms like LIMS, RIS, PACS, and ERP.
4. Strong focus on quality ensures high customer retention.
5. Experienced management team with deep industry expertise.
Risks
1. Limited geographical presence outside eastern and northeastern India.
2. Heavy reliance on technological systems for operations.
3. High competition from national diagnostic chains in expanding markets.
4. Dependence on a fragmented market for growth opportunities.
5. Vulnerability to economic and regulatory changes in the healthcare sector.
in 3
easy steps
Using 5paisa App or
Website
to block Payment
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
FAQs
Suraksha Diagnostic IPO opens from 29 November to 3 December 2024.
The size of Suraksha Diagnostic IPO is ₹846.25 Cr.
The price band of Suraksha Diagnostic IPO is fixed at ₹420 to ₹441 per share.
To apply for Suraksha Diagnostic IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Suraksha Diagnostic IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Suraksha Diagnostic IPO is 34 shares and the investment required is ₹14,994.
The share allotment date of Suraksha Diagnostic IPO is 4 December 2024
The Suraksha Diagnostic IPO will be listed on 6 December 2024.
ICICI Securities Ltd, Nuvama Wealth Management Ltd and SBI Capital Markets Ltd are the book running lead managers of Suraksha Diagnostic IPO.
The company will not receive any proceeds from the Offer. All proceeds will be directed to the Selling Shareholders, based on the number of shares each shareholder sells through the Offer.
